Literature DB >> 19138949

Targeting transcription factors for cancer prevention--the case of Nrf2.

Nancy H Colburn1, Thomas W Kensler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19138949     DOI： 10.1158/1940-6207.CAPR-08-0025

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN： 1940-6215


× No keyword cloud information.
  8 in total

1.  Nrf2 and Keap1 abnormalities in non-small cell lung carcinoma and association with clinicopathologic features.

Authors:  Luisa M Solis; Carmen Behrens; Wenli Dong; Milind Suraokar; Natalie C Ozburn; Cesar A Moran; Alejandro H Corvalan; Shyam Biswal; Stephen G Swisher; B Nebiyou Bekele; John D Minna; David J Stewart; Ignacio I Wistuba
Journal:  Clin Cancer Res       Date:  2010-06-09       Impact factor: 12.531

Review 2.  Regulation of NF-E2-related factor 2 signaling for cancer chemoprevention: antioxidant coupled with antiinflammatory.

Authors:  Rong Hu; Constance Lay-Lay Saw; Rong Yu; Ah-Ng Tony Kong
Journal:  Antioxid Redox Signal       Date:  2010-08-17       Impact factor: 8.401

3.  Tumor promoter-induced sulfiredoxin is required for mouse skin tumorigenesis.

Authors:  Lisha Wu; Hong Jiang; Hedy A Chawsheen; Murli Mishra; Matthew R Young; Matthieu Gerard; Michel B Toledano; Nancy H Colburn; Qiou Wei
Journal:  Carcinogenesis       Date:  2014-02-06       Impact factor: 4.944

4.  Altered hematopoietic cell gene expression precedes development of therapy-related myelodysplasia/acute myeloid leukemia and identifies patients at risk.

Authors:  Liang Li; Min Li; Canlan Sun; Liton Francisco; Sujata Chakraborty; Melanie Sabado; Tinisha McDonald; Janelle Gyorffy; Karen Chang; Shirong Wang; Wenhong Fan; Jiangning Li; Lue Ping Zhao; Jerald Radich; Stephen Forman; Smita Bhatia; Ravi Bhatia
Journal:  Cancer Cell       Date:  2011-11-15       Impact factor: 31.743

5.  Aggressive mammary carcinoma progression in Nrf2 knockout mice treated with 7,12-dimethylbenz[a]anthracene.

Authors:  Lisa Becks; Misty Prince; Hannah Burson; Christopher Christophe; Mason Broadway; Ken Itoh; Masayuki Yamamoto; Michael Mathis; Elysse Orchard; Runhua Shi; Jerry McLarty; Kevin Pruitt; Songlin Zhang; Heather E Kleiner-Hancock
Journal:  BMC Cancer       Date:  2010-10-08       Impact factor: 4.430

6.  Loss of sulfiredoxin renders mice resistant to azoxymethane/dextran sulfate sodium-induced colon carcinogenesis.

Authors:  Qiou Wei; Hong Jiang; Alyson Baker; Lisa K Dodge; Matthieu Gerard; Matthew R Young; Michel B Toledano; Nancy H Colburn
Journal:  Carcinogenesis       Date:  2013-02-07       Impact factor: 4.944

Review 7.  Transduction of redox signaling by electrophile-protein reactions.

Authors:  Tanja K Rudolph; Bruce A Freeman
Journal:  Sci Signal       Date:  2009-09-29       Impact factor: 8.192

8.  Nuclear factor E2-related factor 2 dependent overexpression of sulfiredoxin and peroxiredoxin III in human lung cancer.

Authors:  Young Sun Kim; Hye Lim Lee; Ki Bum Lee; Joo Hun Park; Wou Young Chung; Keu Sung Lee; Seung Soo Sheen; Kwang Joo Park; Sung Chul Hwang
Journal:  Korean J Intern Med       Date:  2011-09-13       Impact factor: 2.884
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.